M02.20 identifies arthropathy that develops as a consequence of vaccination when the affected joint site is not documented or not specified in the medical record.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 6
- Region
- General
Documentation tips
What should appear in the chart to support M02.20.
Source · Editorial brief grounded in 5 cited references ↓
- Record the specific vaccine administered (e.g., influenza, COVID-19, hepatitis B) and the date of immunization to establish the causal relationship between vaccination and joint symptoms.
- Identify and document the specific joint(s) affected by name and laterality — even a brief notation ('left knee swelling post-influenza vaccine') allows upgrade to a site-specific M02.2x code and avoids 'unspecified site' fallback.
- Document the temporal relationship between vaccination and arthropathy onset; payers may challenge causality without a clear timeline in the record.
- If imaging was performed, note the findings (joint effusion, synovitis) in the record to support medical necessity for any associated CPT procedures.
- If multiple joints are involved, list each affected joint explicitly so the coder can determine whether M02.29 (multiple sites) is more accurate than M02.20.
Related CPT procedures
Procedure codes commonly billed with M02.20. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M02.20 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Defaulting to M02.20 when the chart actually names the joint — always check nursing notes, imaging orders, and the vaccine adverse event record before using the unspecified site code.
- Coding M02.20 for arthritis caused by rubella, mumps, or late syphilis — those are Excludes1 conditions with their own dedicated codes (B06.82, B26.85, A52.77) and cannot be coded to M02.2x.
- Omitting the underlying vaccine or immunization event from the encounter documentation, which weakens the causal link and leaves the diagnosis vulnerable to payer audit.
- Confusing postimmunization arthropathy with SIRVA (Shoulder Injury Related to Vaccine Administration) — SIRVA is a mechanical/inflammatory injury from incorrect injection technique and may require different coding; clarify the mechanism with the provider.
- Using M02.20 as a primary diagnosis without verifying that no etiology/manifestation sequencing convention applies — review the full M02 category notes before finalizing code order.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M02.20 is the fallback code within the M02.2 subcategory when joint involvement from a postimmunization arthropathy cannot be assigned to a specific anatomic site. The M02.2x codes cover shoulder (M02.21x), elbow (M02.22x), wrist (M02.23x), hand (M02.24x), hip (M02.25x), knee (M02.26x), ankle and foot (M02.27x), vertebrae (M02.28), and multiple sites (M02.29). Use M02.20 only when the provider's documentation genuinely omits the specific joint — not as a convenience code when the chart contains laterality information.
Postimmunization arthropathy is classified under Postinfective and Reactive Arthropathies (M02). The M02 category carries critical Excludes1 restrictions: do not use these codes when the arthritis is attributable to Behçet's disease (M35.2), rubella (B06.82), mumps (B26.85), late syphilis (A52.77), postmeningococcal arthritis (A39.84), or rheumatic fever (I00). Those conditions have their own specific arthritis codes and must not be coded to M02.2x.
M02.20 is a billable code for FY2026. However, payers and auditors scrutinize 'unspecified site' codes when a specific joint is documented elsewhere in the record — progress notes, imaging reports, or the vaccine adverse event documentation. Query the provider before defaulting to the unspecified code. If bilateral joint involvement is present after vaccination, consider M02.29 (multiple sites) rather than stacking M02.20.
Sibling codes
Other billable codes under M02.2 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When is M02.20 appropriate instead of a site-specific M02.2x code?
02Which vaccines are associated with postimmunization arthropathy coded to M02.2x?
03Does SIRVA code to M02.20?
04Can M02.20 be the principal diagnosis on a claim?
05What is the difference between M02.20 and M02.29?
06Are there any Excludes1 conditions coders frequently confuse with M02.20?
07Does M02.20 require a 7th character extension?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (FY2026, effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M00-M02/M02-/M02.20
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M02.2
- 04aapc.comhttps://www.aapc.com/codes/icd-10-codes/M02.20
- 05aapc.comhttps://www.aapc.com/codes/icd-10-codes/M02
Mira AI Scribe
Mira AI Scribe captures the specific joint name, laterality, vaccine type, and date of immunization directly from the encounter note and vaccine administration record. That specificity allows upgrade to a site-specific M02.2x code — preventing the 'unspecified site' flag that draws payer scrutiny and prevents downcoding on joint injection or imaging claims tied to this diagnosis.
See how Mira captures M02.20 documentation